Immunization with the long-acting monoclonal antibody nirsevimab may provide stronger protection against hospitalizations for ...
Six recent studies conclude that maternal respiratory syncytial virus (RSV) vaccination and the long-acting monoclonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results